A longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT): Protocol for a phase II feasibility pilot randomized controlled trial.

Tam, Samantha; Kumar, Rajat; Lopez, Paty; Mattsson, Jonas; Alibhai, Shabbir; Atenafu, Eshetu G; Bernstein, Lori J; Chang, Eugene; Clarke, Susan; Langelier, David; Lipton, Jeffrey; Mayo, Samantha; Papadakos, Tina; Jones, Jennifer Michelle

Tam, Samantha; Kumar, Rajat; Lopez, Paty; Mattsson, Jonas; Alibhai, Shabbir; Atenafu, Eshetu G; Bernstein, Lori J; Chang, Eugene; Clarke, Susan; Langelier, David; Lipton, Jeffrey; Mayo, Samantha; Papadakos, Tina; Jones, Jennifer Michelle.

Affiliation

Tam S; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Kumar R; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Lopez P; Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Mattsson J; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Alibhai S; Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Atenafu EG; General Internal Medicine, University Health Network, Toronto, Ontario, Canada.
Bernstein LJ; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Chang E; Department of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Clarke S; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Langelier D; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Lipton J; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Mayo S; Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Papadakos T; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Jones JM; Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

PLoS One ; 18(5): e0285420, 2023.

Article de En | MEDLINE | ID: mdl-37192195

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Moelle osseuse / Transplantation de cellules souches hématopoïétiques Type d'étude: Clinical_trials / Qualitative_research / Risk_factors_studies Aspects: Implementation_research Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Canada Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google